Skip to content
Feral Cat LogoGovInfoNow
FDA drug shortage status

Is Atazanavir Sulfate; Cobicistat Tablet (Evotaz) in shortage?

Atazanavir Sulfate; Cobicistat Tablet is listed by FDA as being discontinued by at least one maker (updated Nov 3, 2025).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Evotaz, Tablet, 300 mg; 150 mg (NDC 0003-3641-11)
    Bristol Myers Squibb Co.Being discontinuedUpdated Nov 3, 2025Discontinued Nov 3, 2025

    The global Cease Manufacture date for EVOTAZ® currently is estimated to begin April 2026.

    Maker contact: 800-332-2056

Other forms on FDA’s list

Atazanavir Sulfate; Cobicistat Tablet shortage questions

Is Atazanavir Sulfate; Cobicistat Tablet (Evotaz) in shortage?

Atazanavir Sulfate; Cobicistat Tablet is listed by FDA as being discontinued by at least one maker (updated Nov 3, 2025).

What should I do if I can’t get Atazanavir Sulfate; Cobicistat Tablet?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.